Severe relapses and rebound activity after natalizumab discontinuation in MS patients with more than five years of treatment with stable disease course

被引：0
|
作者：
Fagius, J. [1 ]
Burman, J. [1 ]
Feresiadou, A. [1 ]
Larsson, E. -M. [2 ]
机构：
[1] Uppsala Univ, Neurosci Neurol, Uppsala, Sweden
[2] Uppsala Univ, Surg Sci Radiol, Uppsala, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P618
引用
收藏
页码：297 / 297
页数：1
相关论文
共 50 条
  • [31] The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma
    van der Sangen, MJC
    van de Poll-Franse, LV
    Roumen, RMH
    Rutten, HJT
    Coebergh, JWW
    Vreugdenhil, G
    Voogd, AC
    EJSO, 2006, 32 (01): : 34 - 38
  • [32] Outcome of soft-tissue sarcoma patients who were alive and event-free more than five years after initial treatment
    Nakamura, T.
    Grimer, R. J.
    Carter, S. R.
    Tillman, R. M.
    Abudu, A.
    Jeys, L.
    Sudo, A.
    BONE & JOINT JOURNAL, 2013, 95B (08): : 1139 - 1143
  • [33] Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study
    van der Maas, Aatke
    Kievit, Wietske
    van den Bemt, Bart J. F.
    van den Hoogen, Frank H. J.
    van Riel, Piet L.
    den Broeder, Alfons A.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) : 1849 - 1854
  • [34] Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls
    De Panfilis, G
    Melzani, G
    Mori, G
    Ghidini, A
    Graifemberghi, S
    SEXUALLY TRANSMITTED DISEASES, 2002, 29 (03) : 121 - 125
  • [35] Favorable clinical course after discontinuation of omalizumab treatment in patients with allergic severe asthma: A real-world clinical practice
    Hamada, Satoshi
    Ogino, Eriko
    Yasuba, Hirotaka
    RESPIRATORY INVESTIGATION, 2024, 62 (05) : 762 - 765
  • [36] Effect of two-year discontinuation after five years of alendronate treatment in patients with postmenopausal osteoporosis and impaired fasting glucose
    Cokolic, M.
    Hren, R.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S260 - S260
  • [37] Effect of two-year discontinuation after five years alendronate treatment in patients with postmenopausal osteoporosis and impaired fasting glucose
    Cokolic, M.
    Hren, R.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S88 - S88
  • [38] More Alemtuzumab Relapsing-Remitting Multiple Sclerosis Patients Are Free of Clinical Disease Activity at Five Years
    Twyman, Cary
    NEUROLOGY, 2011, 76 (09) : A563 - A564
  • [39] Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable Remission
    Hagen, Melanie
    Tascilar, Koray
    Reiser, Michaela
    Haschka, Judith
    Kleyer, Arnd
    Valor, Larissa
    Manger, Bernhard
    Schett, Georg
    Rech, Juergen
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [40] Loss of molars in periodontally treated patients:: a retrospective analysis five years or more after active periodontal treatment
    Dannewitz, B
    Krieger, JK
    Hüsing, J
    Eickholz, P
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2006, 33 (01) : 53 - 61
12345